The effect of finasteride on prostate specific antigen: Review of available data

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 3-9

  Guess, Harry A ^a   Gormley, Glenn J ^a   Stoner, Elizabeth ^a   Oesterling, Joseph E ^a  

^a NONE

Author keywords

Antigens, neoplasm; Finasteride; Prostatic hypertrophy; Prostatic neoplasms

Indexed keywords

FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER CHEMOTHERAPY; CLINICAL TRIAL; HUMAN; MALE; NORMAL VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW; SERUM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CLINICAL TRIALS; ENZYME INHIBITORS; FINASTERIDE; HUMAN; MALE; MIDDLE AGE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TESTOSTERONE 5-ALPHA-REDUCTASE; TIME FACTORS;

EID: 0029656028     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66524-8     Document Type: Review

References (33)

1. Gormley, G. J., Stoner, E., Bruskewitz, R. C., Imperato-McGinley, J., Walsh, P. C., McConnell, J. D., Andriole, G. L., Geller, J., Bracken, B. R., Tenover, J. S., Vaughan, E. D., Pappas, F., Taylor, A., Binkowitz, B. and Ng, J.: The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. New Engl. J. Med., 327: 1185, 1992.
2. Guess, H. A., Heyse, J. F. and Gormley, G. J.: The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia. Prostate, 22: 31, 1993.
3. Guess, H. A., Heyse, J. F., Gormley, G. J., Stoner, E. and Oesterling, J. E.: Effect of finasteride on serum PSA concentrations in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial. Urol. Clin. N. Amer., 20: 627, 1993.
4. Gormley, G. J., Ng, J., Cook, T., Stoner, E., Guess, H. and Walsh, P.: Effect of finasteride on prostate-specific antigen density. Urology, 43: 53, 1994.
5. Stoner, E.: Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group. Arch. Intern. Med., 154: 83, 1994.
6. Stoner, E.: Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia. Urology, 43: 284, 1994.
7. Presti, J. C., Jr., Fair, W. R., Andriole, G., Sogani, P. C., Seidmon, E. J., Ferguson, D., Ng, J. and Gormley, G. J.: Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer. J. Urol., 148: 1201, 1992.
8. Bach, M. A., Tocker, P. F., Malice, M.-P., Baert, L. V. M., Bartsch, G., Beisland, H. O., Einarsson, G. V., Ekman, P., Gingell, J. C., Iversen, P., Johansen, T. E. B., Kirk, D., Krarup, T., Nurmi, M., Tammela, T., Varenhorst, E., Wolf, H., Waldstreicher, J., Stoner, E. and Gormley, G. J.: The effects of finasteride on serum prostate specific antigen (PSA) in men with benign prostatic hyperplasia (BPH) and prostate cancer (PCa). J. Urol., part 2, 153: 397A, abstract 673, 1995.
9. Waldstreicher, J., Tocker, P. F., Cheng, J., Shown, T. E., Hampsey, J. P., Roy, J. B., Hudson, P. B., Oesterling, J. E., Lieber, M. M., Imperato-McGinley, J., Ellis, W. J., Sugimoto, D., Bach, M. A., Stoner, E. and Gormley, G. J.: The effects of finasteride on serum prostate specific antigen (PSA) in men with benign prostatic hyperplasia. J. Urol., part 2, 153: 396A, abstract 672, 1995.
10. Stoner, E. and Guess, H.: Treatment of benign prostatic hyperplasia with five alpha inhibitors. Endocrinology 5: 140, 1995.
11. Oesterling, J. E.: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907, 1991.
12. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
13. Collins, G. N., Lee, R. J., McKelvie, G. B., Rogers, A. C. N. and Hehir, M.: Relationship between prostate specific antigen, prostate volume, and age in the benign prostate. Brit. J. Urol., 71: 445, 1993.
14. Dalkin, B. L., Ahmann, F. R. and Kopp, J. B.: Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma. J. Urol., 150: 1837, 1993.
15. Crawford, E. D.: Report on the 1993 prostate cancer awareness week. Presented at annual meeting of American Urological Association, San Francisco, California, May 14-19, 1994.
16. Feneley, M. R., McLean, A., Webb, J. A. W. and Kirby, R. S.: Age corrected prostate specific antigen in symptomatic benign prostatic hyperplasia. J. Urol., part 2, 151: 312A, abstract 337, 1994.
17. Carter, H. B., Pearson, J. D., Metter, E. J., Brant, L. J., Chan, D. W., Andres, R., Fozard, J. L. and Walsh, P. C.: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. J.A.M.A., 267: 2215, 1992.
18. Hanley, J. A. and McNeil, B. J.: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143: 29, 1982.
19. Gann, P. H., Hennekens, C. H. and Stampfer, M. J.: A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. J.A.M.A., 273: 289, 1995.
20. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
21. Stamey, T. A., Kabalin, J. N., McNeal, J. E., Johnstone, I. M., Freiha, F. S., Redwine, E. A. and Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol., 141: 1076, 1989.
22. Benson, M. C., Whang, I. S., Pantuck, A., Ring, K., Kaplan, S. A., Olsson, C. A. and Cooner, W. H.: Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol., 147: 815, 1992.
23. Stenman, U. H., Leinonen, J., Alfhan, H., Rannikko, S., Tuhkanen, K. and Alfthan, O.: A complex between prostate-specific antigen and alphal-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222, 1991.
24. Lilja, H.: Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to α1-antichymotrypsin. Urol. Clin. N. Amer., 20: 681, 1993.
25. Frazier, H. A., Robertson, J. E., Humphrey, P. A. and Paulson, D. F.: Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. J. Urol., 149: 516, 1993.
26. Abi-Aad, A. S., MacFarlane, M. T., Stein, A. and deKernion, J. B.: Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound. J. Urol., 147: 952, 1992.
27. Lightner, D. J., Lange, P. H., Reddy, P. K. and Moore, L.: Prostate-specific antigen and local recurrence after radical prostatectomy. J. Urol., 144: 921, 1990.
28. Andriole, G., Lieber, M., Smith, J., Soloway, M., Schroeder, F., Kadmon, D., deKernion, J., Rajfer, J., Boake, R., Crawford, D., Ramsey, E., Perreault, J., Trachtenberg, J., Fradet, Y., Block, N., Middleton, R., Ng, J., Ferguson, D., and Gormely, G. J.: Treatment with finasteride following radical prostatectomy for prostate cancer. Urology, 45: 491, 1995.
29. Smith, J. A., Jr.: New methods of endocrine management of prostatic cancer. J. Urol., 137: 1, 1987.
30. Huggins, C., Stevens, R. E. and Hodges, C. V.: Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch. Surg., 43: 209, 1943.
31. Petrow, V., Padilla, G. M., Mukherji, S. and Marts, S. A.: Endocrine dependence of prostatic cancer upon dihydrotestosterone and not upon testosterone. J. Pharm. Pharmacol., 36: 352, 1984.
32. Petrow, V.: The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications. Prostate, 9: 343, 1986.
33. Rhodes, L.: Personal communication.